FDA

• FDA approves another abortion pill, sparks conservative backlash

  The FDA approved the original version of mifepristone in 2000 and gradually eased access over time.

  U.S. News

  Oct 3
  
• Infant formula is under health review in the U.S. What parents should know

  The effort launched by U.S. Health Secretary Robert F. Kennedy Jr., dubbed “Operation Stork Speed," is the first deep look at the ingredients in formula since 1998.

  Health

  Jun 3
  
• Advertisement
• Some acne products recalled in U.S. due to benzene, ‘no impact’ in Canada

  The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, though it stressed consumers faced little risk.

  Health

  Mar 14
• Advertisement
• FDA cancels meeting on selecting strains for next season’s flu shot

  A meeting of a committee which advises the U.S. Food and Drug Administration on vaccine policy has been canceled, a committee member told Reuters.

  Health

  Feb 27
• Ozempic, Wegovy shortages are resolved in the U.S.: FDA

  The drugmaker Novo Nordisk can meet present and future demand in the U.S. for its drugs including Ozempic and Wegovy, the U.S. Food and Drug Administration said.

  Health

  Feb 21
• The FDA wants these cold medicines off the shelves. Should Canada follow?

  The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may prompt Canada to review its approval of the drug.

  Health

  Nov 14, 2024
• FDA launches probe after study finds trace toxic metals in tampon brands

  The U.S. FDA has launched an investigation into the safety of tampons following a study that found trace amounts of toxic metals, such as arsenic and lead, in various brands.

  Consumer

  Sep 11, 2024
• Does your cinnamon contain lead? What to know after FDA warning

  The U.S. FDA issued a health advisory Wednesday warning consumers about six brands of ground cinnamon contaminated with lead.

  Consumer

  Mar 8, 2024
• Advertisement
• FDA approves 2 gene therapies for sickle cell disease

  The U.S. FDA on Friday approved two gene therapies for sickle cell disease from Vertex Pharmaceuticals and CRISPR Therapeutics, as well as from bluebird bio.

  Health

  Dec 8, 2023
• Advertisement
• U.S. FDA proposes ban on hair-straightening chemicals. What about Canada?

  The FDA is considering a ban on certain hair-straightening chemicals that have been used by Black women for years and that research shows may increase the risk of uterine cancer.

  Health

  Oct 20, 2023